IFT81 and neoplasm: To collect further evidence for the tumor specificity of the two cryptic peptides RVYLDIVTPK (IFT81) and RLSSSLPSR (ST3GAL6), we evaluated their immunogenicity applying an in vitro priming assay (Figure 4).